The second in a series of webinars on the management of diabetes. This webinar, presented by associate professor Gary Kilov, updates viewers on individualised insulin therapy for patients with type 2 diabetes
The first in a series of webinars on the management of diabetes. This webinar, presented by associate professor Gary Kilov, updates viewers on the importance of glycaemic control for reducing the risk of complications from type 2 diabetes
Relative energy deficiency in sport is an important issue in modern sport. As such, it is important for the GP who cares for athletes to have some knowledge of its genesis and the principles of management, says sports physician Chris Milne
Dulaglutide has been funded for patients with type 2 diabetes since 1 September under Special Authority criteria. This case study summarises its potential benefits and risks, and how these should be considered when tailoring treatment to the individual
Menopause can be a challenging time of life for women, many of whom seek relief from distressing symptoms that affect their function and quality of life. In this article, Susannah O’Sullivan describes how to tailor treatment to each individual woman, while remembering to engage them in discussion of other midlife health considerations
Maree is struggling to manage her diabetes. Recent hypoglycaemic episodes prompt a review of her insulin regimen, with a switch to intermediate-acting insulin and addition of empagliflozin proving beneficial
The absorption of medicines for iron deficiency anaemia and hypothyroidism is affected by long-term proton-pump inhibitor use. This case study describes these interactions and the effect the prescribing cascade can have on thyroid function
Your patient uses gliclazide and insulin but could still benefit from the additional cardiovascular and renal protections of empagliflozin. How would you manage the change in treatment?
The arrival of funded empagliflozin has been eagerly awaited by many. As you start prescribing it to patients meeting Pharmac’s new Special Authority criteria, here’s a hypothetical case study illustrating one possible adverse effect to be aware of
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management